Clofarabine
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 668 publications
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis.
Journal: Blood advances
Published: February 11, 2026
Clinical Efficacy Analysis of 38 Pediatric Cases of Recurrent and Refractory Langerhans Cell Histiocytosis
Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 08, 2026
Synthesis of Triphosphate Nucleoside Prodrugs: γ-ProTriPs.
Journal: Current protocols
Published: December 22, 2025
Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors.
Journal: Cancer chemotherapy and pharmacology
Published: November 21, 2025
Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.
Journal: JCO precision oncology
Published: October 02, 2025
Clofarabine monotherapy in refractory multisystem LCH with gastrointestinal involvement.
Journal: Pediatric hematology and oncology
Published: September 24, 2025
Safety and efficacy of clofarabine for preconditioning intervention in patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphoblastic leukemia.
Journal: International journal of hematology
Published: September 19, 2025
Risk factors for alloimmune lung syndromes after allogeneic hematopoietic cell transplantation in children.
Journal: Bone marrow transplantation
Published: August 27, 2025
Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.
Journal: Cell death & disease
Published: August 03, 2025
Discovery of a novel non-toxic analog of clofarabine for the treatment of triple-negative breast cancer.
Journal: Bioorganic & medicinal chemistry letters
Published: June 20, 2025
Last Updated: 06/30/2026